Rolufta Ellipta
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Rolufta Ellipta, covering 2025-03-28 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Rolufta Ellipta (previously Rolufta) (umeclidinium bromide) — GlaxoSmithKline Trading Services Limited